Ranbaxy launches pravastatin sodium tablets in US

Monday, 25 June 2007, 07:00 Hrs
Printer Print Email Email
Mumbai: Indian pharmaceutical major Ranbaxy Laboratories Ltd Monday said it had launched in the US pravastatin sodium tablets, meant for heart diseases.

Being the first-to-file, the company will enjoy a 180-day exclusivity for the pravastatin 80mg and benefit from the commercial gains during the period, it informed the Bombay Stock Exchange (BSE).

The annual sales for the tablets, used for prevention of several types coronary heart diseases, were $209 million, it said.
Source: IANS
SPOTLIGHT
GST rate cut to spur Bengaluru
The realty market in India's tech hub is set to grow as lower Goods and Services Tax (GST) rate..
Ola raises Rs 400 cr for electric
Leading ride-hailing cab aggregator Ola on Friday said it raised Rs 400 crore from its early in..
Fossil Group sells smartwatch
Global watch and accessories maker Fossil Group has announced to sell its smartphone technolog..
SpiceJet plans aggressive
Budget passenger carrier SpiceJet plans to aggressively expand its international networks to fl..